Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Insys Therapeutics Inc (INSYQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Insys historical data, for real-time data please try another search
0.04 0.00    0.00%
18/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.04 - 0.05
Insys 0.04 0.00 0.00%

INSYQ User Rankings

 
Users ranking according to the performance of their sentiments for the Insys Therapeutics Inc stock.
RankUsernameTotalClosedWinningWin %Chg. %
1LUIS MARTIN GARCIA1111872.73+396.58%
2Franco Grasso22150+220.89%
3raymond colas77685.71+214.09%
4Alex Allueva Delgado111100+197.89%
5Jaime Gonzalez Uria111100+184.42%
6Paulo Peixoto111100+183%
7Dawid Pustelnik111100+178.82%
8Pinco Panco111100+150%
9JRay Law111100+126.4%
10Assaf Admon111100+122.83%
11Jose Azorin44375+106.36%
12michel schaefer111100+89.18%
13jean noel fabre111100+87.32%
14Marc Vanvaerenbergh111100+86.74%
15Łukasz Ślesiński111100+81.39%
16kevin seiler111100+81.12%
17Kóródi István111100+71.63%
18Vladimir Yevtushenko555100+70.54%
19Luka Novak111100+70.48%
20Alessandro Marongiu111100+70%
21Jb Ross111100+69.06%
22Thành Lê111100+68.57%
23Orietta Scarci111100+68.57%
24Martina frias terres111100+65.48%
25Stephen Berry111100+64.52%
26Ro Hof22150+63.61%
27Jackie Patterson111100+63.15%
28Ciprian Bujor111100+63.04%
29Сергей Иванов44375+62.25%
30Johan Hallgren111100+62.07%
31Mário Hernandez111100+61.68%
32MARC BARBERIS111100+61.4%
33Lars Lundby111100+60.71%
34Chris Gabriele Doyo111100+60.71%
35José Prados111100+56.86%
36Kathy Bagnell111100+56%
37Dmitriy Kapish111100+55.1%
38Davide Galanti111100+53.19%
39Ernesto Maristany333100+51.16%
40Rick Lindsay111100+51.11%
41Franck Lejeune222100+51.09%
42לאה נאור111100+50.33%
43Nick Deepwood111100+50%
44Debra Kline111100+49.34%
45Sergio Gutiérrez22150+49.18%
46Robert Bruseth111100+48.84%
47Deniz Akan111100+48.84%
48ramy ibra111100+47.62%
49Alberto Pala22150+45.83%
50Valentin Frg22150+44.51%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INSYQ Comments

Write your thoughts about Insys Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
mauricio merino
mauricio merino May 12, 2020 11:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this company going to be listed again or has it completely disappeared?
mauricio merino
mauricio merino May 12, 2020 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this company going to be listed again or has it completely disappeared?
Noman Bashir
Noman Bashir Oct 17, 2019 12:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it still safe to buy insys stock? it keeps going up?
Yuly Cardona
Yuly Cardona Sep 27, 2019 1:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any thoughts on INSYQ
Florin Ciprian
Florin Ciprian Jun 24, 2019 12:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think delisted soon
Trader One Maniac
Trader One Maniac Jun 19, 2019 6:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After hour -12.40%... time to jump in?
Ze Mily
Ze Mily Jun 17, 2019 8:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://stocktwits.com/Sennacherib/message/167759761
Ze Mily
Ze Mily Jun 17, 2019 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://stocktwits.com/Sennacherib/message/167760672 #insys not delisted. They have confirm for buyout within 90 days
Bullish Bears
Bullish Bears May 21, 2019 10:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wont be long till it delists
Ze Mily
Ze Mily May 21, 2019 10:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is it not moving
Nasty plr
Nastyplr May 14, 2019 5:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email